Sectors
Neutral Today, we are removing our downgrade alert from the S&P semiconductors index on the back of an improving macro backdrop. First and foremost, the semi sales cycle is tied to global rates that tend to lead by approximately 18 months. As Central Banks across the globe are committed to remain on the easening path, global semi sales will likely rebound further (middle panel). A revival of chip M&A activity which effectively reduces the supply of stocks does not show any signs of abating, and will continue to underpin semi stocks as premia paid remain elevated (bottom panel). Bottom Line: We remain neutral the S&P semiconductors index, but are removing our downgrade alert. On a related note, our underweight stance in the sister chip equipment index remains intact. Stay tuned.
We take the opportunity presented by this week’s indiscriminate equity market selloff to pocket in gains from our long December 2020 expiry VIX futures recommendation from the joint Special Report on July 27 with our sister Geopolitical Strategy service. The original rationale was to use December 2020 VIX contracts as a hedge versus long equity exposure in case of a contested US presidential election. The recent vol spike pushed returns over 19.5%, assuming no leverage, compelling us to lock in handsome gains this morning. In a real life example, brokers require 50% margin on VIX futures trading implying that the actual return doubles to 39%. While the VIX can continue to rise on the back of next Tuesday’s election uncertainty, we opt to cash out early as others rush in to buy “expensive” protection too little too late. Bottom Line: Remove the election-related hedge and crystallize 19.5% gains in December 2020 expiry VIX futures contracts.
The equity volatility curve inverted on Monday for the first time since June when the SPX had suffered an 8% pullback. The election and fiscal policy related uncertainty has injected fear back into the equity market and the volatility curve inversion is contrarily positive. As a reminder, a VIX with a 33 handle implies that in the next 30 days the S&P 500 will either fall or rise by roughly 10% and vault to all-time highs or sink back to 3100. While there is a chance that the VIX will continue to roar as it did early in the year and push the vol curve deeper in backwardation, our sense is that the correction that commenced in early September is close to running its course. Historically, the chart shows that the VIX inversion is typically short-lived and more often than not serves as a launchpad for the SPX. Bottom Line: Our view remains that the SPX could glide lower into the November election before rallying into year-end courtesy of receding election and fiscal policy uncertainties.
Neutral – Downgrade Alert Sticking to the spirit of covering defensive sectors in this week’s US Equity Sector Insights, today we turn our attention to a major player by market cap weight in the healthcare sector – the S&P pharmaceuticals index. High odds of a Biden victory weigh heavily on this sector’s prospects as we outlined in the recent joined Special Report with our sister Geopolitical Strategy service (please see “Health Care Stands To Lose The Most From A Blue Sweep” section of the report). Simultaneously, the Fed’s almost overnight drop in the fed funds rate to zero in March, coupled with investors’ further rotation out of defensive and into cyclical stocks on the back of the reopening of the economy, further dampen the allure of Big Pharma (middle & bottom panels). The only reason keeping us from downgrading the sector is a potential spike in relative share prices due to a vaccine or other virus-related news. But our sense is that most of the good news is already priced in. Bottom Line: We are neutral the S&P pharmaceuticals index, but getting ready to pull the trigger on our downgrade alert and trim exposure to below benchmark. Stay tuned. The ticker symbols for the stocks in this index are: BLBG: S5PHAR – JNJ, PFE, MRK, LLY, BMY, ZTS, CTLT, MYL, PRGO.
Your feedback is important to us. Please take our client survey today. Underweight In yesterday’s US Equity Sector Insight we highlighted why investors should stay on the sidelines when it comes to the defensive S&P household products index. But, with regard to the broader S&P consumer staples sector, our view remains that over the next 9-12 months this safe haven sector, which peaked in the depths of the COVID-19 recession, will continue to underperform. As the pandemic-induced recession disappears from the rear-view window, it no longer pays to favor stable cashflow growth staples companies. In fact, our relative macro earnings model paints a dark picture for this GICS1 sector (middle panel). Among other reasons, one of the factors that will drive relative earnings lower is the weaker US dollar. As a reminder, the S&P consumer staples sector derives approximately 32% of its sales from abroad, which is 10 percentage points lower than the S&P 500. As a consequence, on a relative basis staples stocks cannot benefit from positive currency tailwinds to the same extent as the overall market can. Bottom Line: We remain underweight the S&P consumer staples sector.
Neutral We remain neutral the S&P household products index. A V-shaped economic recovery following a recession has historically been synonymous with this defensive industry underperforming (top panel). However, the uniqueness of the current recession must be taken into account. The US consumer continues to binge on household products, which are currently outpacing overall retail sales growth by 13% year-over-year (middle panel, relative consumer spending shown truncated). This trend is slated to continue until a vaccine arrives as the second wave of infections emerges. The same story holds for foreign consumers who also have an incentive to keep up their spending on US household products: a softer US dollar. A weaker US dollar will boost competitiveness of US exporters, which will translate into robust top line growth (bottom panel). Bottom Line: Given the strangeness of the current recession, we remain neutral the S&P household products index. The ticker symbols for the stocks in this index are: BLBG: S5HOPR – PG, CL, KMB, CLX, CHD.
Neutral – Downgrade Alert It no longer pays to chase the S&P homebuilding index higher; it is now on our downgrade alert watch-list. The recent pandemic-induced drubbing in interest rates boosted housing affordability and caused a knee jerk reaction in the mortgage application purchase index, which in turn served as a catalyst for the recent rally (top & middle panels). However, as the economy continues to open up, interest rates will reverse course and flip from a tailwind into a headwind. Sell-side analysts are also upgrading their earnings forecasts at the highest pace since the GFC, and we would lean against this extreme bullishness (bottom panel). Bottom Line: We are neutral the S&P homebuilders index, but it is now on our downgrade watch-list. The ticker symbols for the stocks in this index are: BLBG: S5HOME – LEN, PHM, DHI, NVR. For more details, please refer to the recent Weekly Report.
Neutral – Downgrade Alert Banks hit all-time lows again this week on the back of mixed profit results. While Q3 loan loss reserves will rise albeit at a slower pace than H1/2020, net interest income ails and difficulty in growing revenues are significant offsets. This backdrop makes banks hostage to the 10-year US Treasury yield (top panel). With regard to fiscal stimulus and economic uncertainty, Jamie Dimon recently warned that “If the double-dip (recession) happens, we would be under-reserved by $20 billion.” Worrisomely, the longer the new stimulus checks take to arrive, the longer it will take banks to rebound. Banks have been semi-sheltered from the recession courtesy of eviction/foreclosure moratorium as well as mortgage forbearance agreements. Absent a fresh stimulus package, the unemployment rate will remain elevated, warning that lagging non-performing loans will skyrocket. Bottom Line: Stay neutral the S&P banks index, but keep it on the downgrade watchlist. The ticker symbols for the stocks in this index are: BLBG: S5BANKX – JPM, BAC, C, WFC, USB, TFC, PNC, FRC, FITB, MTB, KEY, SIVB, RF, CFG, HBAN, ZION, CMA, PBCT. For more details, please refer to this Monday’s Weekly Report.
Following up from yesterday’s US Equity Strategy’s sector insight, today we take a closer look at VIX and e-mini futures positioning, again from a contrarian perspective. Using CFTC weekly data, VIX non-commercial speculative positions are net short. In fact, as a percentage of total open interest, net shorts are more extended than the months both prior to “Volmageddon” and to the Q4/2018 20% SPX drawdown. With regard to this year’s equity market carnage, net shorts are almost as extended as in late-2019/early 2020 (VIX net positioning shown inverted, top panel). Similarly, non-commercial speculative positions in S&P 500 e-mini futures are net long on a par with readings recorded in early 2020 (bottom panel). The implication is that speculators are betting on a dying down in volatility and fresh SPX all-time highs. While this will likely materialize post the November election, in the near-term our fear is that speculators will get caught offside, as elevated election and fiscal policy uncertainties will sustain downward pressure on stocks. Bottom Line: Our view remains that the SPX could glide lower into the November election before rallying into year-end.